An optimised GAS-pharyngeal cell biofilm model

Abstract Group A Streptococcus (GAS) causes 700 million infections and accounts for half a million deaths per year. Biofilm formation has been implicated in both pharyngeal and dermal GAS infections. In vitro, plate-based assays have shown that several GAS M-types form biofilms, and multiple GAS vir...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Heema K. N. Vyas, Jason D. McArthur, Martina L. Sanderson-Smith
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/29a2b6c563a244f0a96180d08172d1c2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:29a2b6c563a244f0a96180d08172d1c2
record_format dspace
spelling oai:doaj.org-article:29a2b6c563a244f0a96180d08172d1c22021-12-02T15:51:14ZAn optimised GAS-pharyngeal cell biofilm model10.1038/s41598-021-87377-72045-2322https://doaj.org/article/29a2b6c563a244f0a96180d08172d1c22021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87377-7https://doaj.org/toc/2045-2322Abstract Group A Streptococcus (GAS) causes 700 million infections and accounts for half a million deaths per year. Biofilm formation has been implicated in both pharyngeal and dermal GAS infections. In vitro, plate-based assays have shown that several GAS M-types form biofilms, and multiple GAS virulence factors have been linked to biofilm formation. Although the contributions of these plate-based studies have been valuable, most have failed to mimic the host environment, with many studies utilising abiotic surfaces. GAS is a human specific pathogen, and colonisation and subsequent biofilm formation is likely facilitated by distinct interactions with host tissue surfaces. As such, a host cell-GAS model has been optimised to support and grow GAS biofilms of a variety of GAS M-types. Improvements and adjustments to the crystal violet biofilm biomass assay have also been tailored to reproducibly detect delicate GAS biofilms. We propose 72 h as an optimal growth period for yielding detectable biofilm biomass. GAS biofilms formed are robust and durable, and can be reproducibly assessed via staining/washing intensive assays such as crystal violet with the aid of methanol fixation prior to staining. Lastly, SEM imaging of GAS biofilms formed by this model revealed GAS cocci chains arranged into three-dimensional aggregated structures with EPS matrix material. Taken together, we outline an efficacious GAS biofilm pharyngeal cell model that can support long-term GAS biofilm formation, with biofilms formed closely resembling those seen in vivo.Heema K. N. VyasJason D. McArthurMartina L. Sanderson-SmithNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Heema K. N. Vyas
Jason D. McArthur
Martina L. Sanderson-Smith
An optimised GAS-pharyngeal cell biofilm model
description Abstract Group A Streptococcus (GAS) causes 700 million infections and accounts for half a million deaths per year. Biofilm formation has been implicated in both pharyngeal and dermal GAS infections. In vitro, plate-based assays have shown that several GAS M-types form biofilms, and multiple GAS virulence factors have been linked to biofilm formation. Although the contributions of these plate-based studies have been valuable, most have failed to mimic the host environment, with many studies utilising abiotic surfaces. GAS is a human specific pathogen, and colonisation and subsequent biofilm formation is likely facilitated by distinct interactions with host tissue surfaces. As such, a host cell-GAS model has been optimised to support and grow GAS biofilms of a variety of GAS M-types. Improvements and adjustments to the crystal violet biofilm biomass assay have also been tailored to reproducibly detect delicate GAS biofilms. We propose 72 h as an optimal growth period for yielding detectable biofilm biomass. GAS biofilms formed are robust and durable, and can be reproducibly assessed via staining/washing intensive assays such as crystal violet with the aid of methanol fixation prior to staining. Lastly, SEM imaging of GAS biofilms formed by this model revealed GAS cocci chains arranged into three-dimensional aggregated structures with EPS matrix material. Taken together, we outline an efficacious GAS biofilm pharyngeal cell model that can support long-term GAS biofilm formation, with biofilms formed closely resembling those seen in vivo.
format article
author Heema K. N. Vyas
Jason D. McArthur
Martina L. Sanderson-Smith
author_facet Heema K. N. Vyas
Jason D. McArthur
Martina L. Sanderson-Smith
author_sort Heema K. N. Vyas
title An optimised GAS-pharyngeal cell biofilm model
title_short An optimised GAS-pharyngeal cell biofilm model
title_full An optimised GAS-pharyngeal cell biofilm model
title_fullStr An optimised GAS-pharyngeal cell biofilm model
title_full_unstemmed An optimised GAS-pharyngeal cell biofilm model
title_sort optimised gas-pharyngeal cell biofilm model
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/29a2b6c563a244f0a96180d08172d1c2
work_keys_str_mv AT heemaknvyas anoptimisedgaspharyngealcellbiofilmmodel
AT jasondmcarthur anoptimisedgaspharyngealcellbiofilmmodel
AT martinalsandersonsmith anoptimisedgaspharyngealcellbiofilmmodel
AT heemaknvyas optimisedgaspharyngealcellbiofilmmodel
AT jasondmcarthur optimisedgaspharyngealcellbiofilmmodel
AT martinalsandersonsmith optimisedgaspharyngealcellbiofilmmodel
_version_ 1718385620934459392